Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tanuja Chitnis

Showing results (41-50 of 409) with videos related to

Pageof 41
Sort By:
Expert Review of Neurotherapeutics|April 21, 2020
Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment optionsMattia Rosso, Shrishti Saxena, Tanuja Chitnis
Journal of Neurology|October 9, 2013
Menopause in multiple sclerosis: therapeutic considerationsRiley Bove, Tanuja Chitnis, Maria Houtchens
Journal of Neurology|April 8, 2011
Improving power to detect disease progression in multiple sclerosis through alternative analysis strategiesBrian Healy, Tanuja Chitnis, David Engler
Statistical Methods in Medical Research|February 21, 2015
Joint assessment of dependent discrete disease state processesDavid Engler, Tanuja Chitnis, Brian Healy
Epilepsy & Behavior Reports|August 28, 2019
Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitisJonathan D Santoro, Alexandra Filippakis, Tanuja Chitnis
Archives of Neurology|January 13, 2006
Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapiesJaime Imitola, Tanuja Chitnis, Samia J Khoury
Annals of Clinical and Translational Neurology|November 4, 2020
Blood neurofilament light: a critical review of its application to neurologic diseaseChristian Barro, Tanuja Chitnis, Howard L Weiner
Neurology|November 11, 2009
Body size and risk of MS in two cohorts of US womenKassandra L Munger, Tanuja Chitnis, Alberto Ascherio
Frontiers in Pharmacology|April 9, 2021
Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive EtiologyMaria Popescu, Talia B Feldman, Tanuja Chitnis
Pharmacology & Therapeutics|May 4, 2005
Cytokines in multiple sclerosis: from bench to bedsideJaime Imitola, Tanuja Chitnis, Samia J Khoury
Pageof 41

Showing results (41-50 of 409) with videos related to

Sort By:
Pageof 41
Expert Review of Neurotherapeutics|April 21, 2020
Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment optionsMattia Rosso, Shrishti Saxena, Tanuja Chitnis
Journal of Neurology|October 9, 2013
Menopause in multiple sclerosis: therapeutic considerationsRiley Bove, Tanuja Chitnis, Maria Houtchens
Journal of Neurology|April 8, 2011
Improving power to detect disease progression in multiple sclerosis through alternative analysis strategiesBrian Healy, Tanuja Chitnis, David Engler
Statistical Methods in Medical Research|February 21, 2015
Joint assessment of dependent discrete disease state processesDavid Engler, Tanuja Chitnis, Brian Healy
Epilepsy & Behavior Reports|August 28, 2019
Ketamine use in refractory status epilepticus associated with anti-NMDA receptor antibody encephalitisJonathan D Santoro, Alexandra Filippakis, Tanuja Chitnis
Archives of Neurology|January 13, 2006
Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapiesJaime Imitola, Tanuja Chitnis, Samia J Khoury
Annals of Clinical and Translational Neurology|November 4, 2020
Blood neurofilament light: a critical review of its application to neurologic diseaseChristian Barro, Tanuja Chitnis, Howard L Weiner
Neurology|November 11, 2009
Body size and risk of MS in two cohorts of US womenKassandra L Munger, Tanuja Chitnis, Alberto Ascherio
Frontiers in Pharmacology|April 9, 2021
Interplay Between Endocrine Disruptors and Immunity: Implications for Diseases of Autoreactive EtiologyMaria Popescu, Talia B Feldman, Tanuja Chitnis
Pharmacology & Therapeutics|May 4, 2005
Cytokines in multiple sclerosis: from bench to bedsideJaime Imitola, Tanuja Chitnis, Samia J Khoury
Pageof 41